Navigation Links
Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
Date:9/2/2011

SUNNYVALE, Calif., Sept. 2, 2011 /PRNewswire/ -- Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced the addition of the TUNE detection cartridge to the SpectraMax Paradigm Multi-Mode Microplate Detection Platform. The breakthrough technology of TUNE with wavelength flexibility in a monochromator device and up to 10x the sensitivity will benefit both the research and screening markets.

(Logo:  http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)

The SpectraMax Paradigm Detection Platform is the only user upgradeable microplate reader on the market today. It allows the user to read what they want, when they want. Now, with the TUNE detection cartridge, the Paradigm system is the most flexible instrument available. The patent pending Spectral Optimization Wizard in SoftMax® Pro software reduces the assay set up time by more than 50% with simultaneous scanning of excitation and emission spectrums.

Flexibility for Research

For the researchers who need the wavelength flexibility of a monochromator in fluorescent applications, TUNE will offer unmatched sensitivity allowing them to test new assays and further advance their research. The flexibility of the Paradigm platform and ability to easily add future options, makes it a great investment for their labs.

Speed of Paradigm with Sensitivity of TUNE, Ideal for Screening

The TUNE cartridge enables monochromator-like wavelength flexibility without compromising on sensitivity. The Paradigm platform is built with on-the-fly detection for reduced read times, plate format of up to 1536-wells, dual PMTs, and was designed with automation in mind, all important features for high throughput. Use of the TUNE cartridge with the Paradigm instrument will meet the needs of screeners with high sensitivity and
'/>"/>

SOURCE Molecular Devices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pathologists Gather to Focus on Advances in Molecular Testing, Digital Imaging, and Biospecimens
2. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
3. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
4. Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation
5. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
6. Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
7. Amsterdam Molecular Therapeutics Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients
8. Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
9. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
10. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
11. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... addition of the "Global Insulin Patch Market ... Highly advanced technology like ultrasound and iontophoresis ... insulin patches. Depending upon the type of technique, ... of reach of several patients. In long-term, it ...
(Date:5/6/2015)...   CEFALY Technology , the creators of the ... for use prior to the onset of migraine pain, ... at the EUROHEADPAIN - Midterm Meeting at the International ... , from May 14-17, 2015. On May ... major European research project focused on migraines, CEFALY ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
Breaking Medicine Technology:Global Insulin Patch Market Opportunity Analysis 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... Therapy Reduces TNF-alpha Production Through Inhibition,of PDE-4 ... /PRNewswire/ -- Anacor,Pharmaceuticals, a privately held pharmaceutical ... Phase 1 trial of,AN2728, a first-in-class topical ... The trial showed AN2728 to be,well-tolerated, with ...
... and Pharmacokinetics Similar to IV Doses in,Phase ... 06, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated announced the ... Company's lead anti-cancer drug,Genasense(R) (oblimersen sodium) injection, ... injection, as well,as by brief intravenous (IV) ...
Cached Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4
(Date:5/6/2015)... Illinois (PRWEB) May 06, 2015 RPS Revolution ... take on the tried and true Rock Paper Scissors game ... With fun characters that encourage storytelling and easy to learn ... new twist on an old favorite. RPS Revolution ... it into whimsical characters that are grouped in set of ...
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the ... Ting will lead a discussion about the Internet of ... user authentication challenges, during Citrix Synergy (May ... on the benefits of creating a network of IP-connected ... patients can share information. It will also emphasize the ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, after ... Florida while under the influence of Flakka, according to ... by CBS4’s Peter D’Oench records Doby distraught in a parking ... one year old. The drug treatment center in Florida who ... The residents polled by CBS Miami express concern about the ...
(Date:5/6/2015)... The Canton Group is joining Lardarius Webb ... annual charity softball game. The event takes place on Friday, ... Past years guests include Joe Flacco, John Harbaugh, Ed Reed ... sale if you are interested in attending. , The ... as SOAR Baltimore and The CollegeBound Foundation ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TMG Health, ... to the Medicare Advantage, Medicare Part D and Managed ... Continuity and Resilience Team category at the BCI North ... Institute to recognize the outstanding contribution of business continuity ... North America Region, including the USA and Canada. The ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... , OMAHA, Neb. and PHOENIX, Ariz., June 30 ... Joseph,s Hospital and Medical Center in Phoenix today announced an ... school presence in Phoenix. , , The Phoenix ... School of Medicine at St. Joseph,s Hospital and Medical Center, ...
... infection to treat and requires six months of multiple ... pandemic, a shorter and simpler drug treatment would be ... settings with poor public health infrastructures. ... which TB patients could benefit from shorter treatment, researchers ...
... Community Improvement , , MINNEAPOLIS, June 30 ... and a leader in financial clearing services for health ... the Ernst & Young Entrepreneur Of The Year(R) 2009 ... region. According to Ernst & Young LLP, the award ...
... Partnership to Fight Chronic Disease (PFCD), a coalition committed to ... comprehensive health reform, hosted a breakfast meeting today where partner ... and care. , , America spends more ... percent - or $1.7 trillion - of that spending is ...
... Ultrasound in Medicine (AIUM) has reached a management ... (ISTU) effective July 1, 2009. The AIUM will ... functions in an effort to maximize the ISTU,s ... "The AIUM recognizes therapeutic ultrasound as a ...
... 30 /PRNewswire/ - Winnipeg-based medical device company Intelligent ... Century Achievement Award during the Computerworld Honors Program ... D.C. IH Systems received the award in recognition ... world,s first solution combining software, robotics and engineering ...
Cached Medicine News:Health News:Creighton University, St. Joseph's Hospital and Medical Center Announce New School of Medicine Campus in Phoenix 2Health News:Measurements fail to identify TB patients who could benefit from shorter treatment course 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 3Health News:Delaware's Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health 2Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2
... matrix constructed of cross-linked collagen fibers ... through a proprietary 360 accretion process. ... aspirate, Healos provides an excellent environment ... differentiation. The hydroxyapatite-coated collagen microfibers in ...
Sharp Weitlaner Retractor....
Weitlaner retractor, blunt....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
Medicine Products: